Home
Healthy Lifestyle

ADHD in Women: Why Diagnosis Often Comes Later in Life

ADHD in Women: Why Diagnosis Often Comes Later in Life
ADHD in Women: Why Diagnosis Often Comes Later in Life

ADHD in Women: Why Diagnosis Often Comes Later in Life

For decades, attention-deficit/hyperactivity disorder (ADHD) was considered primarily a male condition. The stereotypical image—a young boy bouncing off the walls, unable to sit still in class—shaped not only public perception but also the diagnostic criteria themselves. This male-centric framework has had a lasting consequence: millions of women with ADHD have been missed, misdiagnosed, or diagnosed only after years of unnecessary struggle.

The numbers tell a stark story. While ADHD affects men and women at roughly the same rate, men are diagnosed far more often—13% of men compared to only 4.2% of women. This discrepancy is not because women are less susceptible, but because their symptoms are less visible, more internalised, and frequently attributed to other causes. Women are diagnosed approximately 4 to 5 years later than men, despite symptoms appearing at the same age. A study presented at the ECNP Congress (2024) found that women received their first ADHD diagnosis at an average age of 29 years, compared to 24 years for men. A commentary on Skoglund et al. (2023) notes a nearly 4-year delay in diagnosis for women, even though they have high rates of prior contact with the mental health care system.

This delay is not trivial. It represents years of missed treatment, worsening symptoms, and accumulating impairment. Understanding why ADHD in women is so often missed is the first step toward changing this pattern.

The Inattentive Presentation: A Quieter Symptom Profile

The most fundamental reason ADHD is overlooked in women is the symptom presentation. While boys with ADHD more often display the hyperactive-impulsive subtype—characterised by overt physical restlessness, impulsivity, and disruptive behaviour—girls are far more likely to present with the predominantly inattentive subtype. Their symptoms are quieter: daydreaming, distractibility, forgetfulness, disorganisation, and a tendency to appear "spaced out" rather than disruptive.

These symptoms do not attract the same attention in the classroom or the workplace. A boy who cannot sit still is noticed; a girl who is quietly distracted is often dismissed as lazy, unmotivated, or simply not trying hard enough. The externalising behaviours that prompt referral in boys are largely absent in girls, whose difficulties are internalised and therefore less visible.

This pattern persists into adulthood. Women with ADHD often describe a lifelong struggle with mental fog, difficulty prioritising tasks, chronic lateness, and a sense of being overwhelmed by everyday responsibilities. They may appear to be functioning adequately, but at great internal cost. As one clinician put it, "Girls, on the other hand, tend to have more inattentive symptoms, where they're zoning out, daydreaming or distracted. Because these symptoms are less disruptive, they're more likely to go unnoticed".

Masking and Compensation: The Hidden Struggle

Perhaps the most significant barrier to diagnosis in women is the phenomenon of masking. Masking refers to the conscious or unconscious suppression of ADHD symptoms in order to fit in with social expectations. Women with ADHD often work exceptionally hard to hide their difficulties—developing elaborate coping strategies, overcompensating through perfectionism, and creating rigid routines to maintain the appearance of control.

This masking is not simply a personal choice; it is shaped by gendered societal norms and expectations. From an early age, girls are socialised to be organised, attentive, and emotionally regulated. When they struggle with these expectations, they internalise their failures and redouble their efforts to appear "normal." This can be exhausting, and it often delays diagnosis until the compensatory strategies collapse under the weight of adult responsibilities.

Masking also complicates the diagnostic process. When a woman presents to a clinician, she may appear articulate, organised, and high-functioning—because she has spent years perfecting that appearance. Her internal struggles may not be immediately apparent, and she may not even recognise them as symptoms of a neurodevelopmental condition. As one review notes, "reasons for women with internalised symptoms being diagnosed with ADHD later in life has been suggested to be due to 'masking' symptoms".

This is not just about hiding symptoms from others; it is also about hiding them from oneself. Many women with undiagnosed ADHD attribute their difficulties to personal failings—laziness, lack of discipline, or not trying hard enough—rather than recognising them as symptoms of a legitimate medical condition.

Misdiagnosis: The Anxiety-Depression Trap

When women with ADHD do seek help, they are frequently misdiagnosed. Up to 75% of adult women with ADHD are estimated to have been misdiagnosed, often with anxiety, depression, or borderline personality disorder, before finally receiving an accurate ADHD diagnosis. This is not surprising: the internalised symptoms of inattentive ADHD—poor concentration, fatigue, irritability, and restlessness—overlap significantly with those of generalised anxiety disorder and major depressive disorder.

Clinicians may treat the anxiety or depression without ever identifying the underlying ADHD. In many cases, the anxiety and depression are actually consequences of undiagnosed ADHD: years of struggling to meet expectations, chronic procrastination, and continuous self-blame lead to severe emotional distress. Treating the anxiety without addressing the ADHD is like treating the smoke without putting out the fire.

Women with ADHD are more likely than men to experience anxiety, depression, and other internalising disorders. These comorbidities can further complicate the diagnostic picture, as symptoms are attributed to the comorbid condition rather than recognised as part of the ADHD presentation. The result is a diagnostic odyssey that can last for years or even decades.

Hormonal Influences: The Missing Piece

One of the most important—and most overlooked—factors in ADHD diagnosis in women is the role of hormones. Hormonal fluctuations across the menstrual cycle, pregnancy, and perimenopause have a significant impact on ADHD symptoms, yet this dimension is rarely considered in diagnostic criteria or clinical training.

Oestrogen plays a key role in modulating dopamine pathways, which are central to attention, executive function, and emotional regulation. When oestrogen levels drop—during the late luteal phase of the menstrual cycle, postpartum, or perimenopause—dopamine levels also decline, leading to a worsening of ADHD symptoms. Many women with ADHD report that their symptoms are most severe in the days just before and during menstruation, when oestrogen is at its lowest.

These hormonal shifts can tip previously manageable symptoms into clinically significant impairment. A woman who was able to cope during her 20s may find that her symptoms become unmanageable after childbirth or during perimenopause, prompting her to seek help for the first time. As one source explains, "cyclical hormonal fluctuations, and especially rapid declines in oestrogen, appear to exacerbate ADHD symptoms". This is not a coincidence; it is a biological reality that has been largely ignored in ADHD research and clinical practice.

The impact of hormones on ADHD has significant implications for diagnosis and treatment. Clinicians should ask about menstrual cycle phase when evaluating symptoms, as symptoms may be more severe during the late luteal phase and less severe during the follicular phase. Failure to account for these fluctuations can lead to underdiagnosis, particularly if a woman is assessed during a phase when her symptoms are relatively mild.

Hormonal transitions also affect treatment response. Some women find that their usual ADHD medication is less effective during the late luteal phase, requiring dose adjustments. This is an area that requires further research, but it underscores the need for a more nuanced, female-specific approach to ADHD management.

Emotional Dysregulation and Rejection Sensitivity

Another feature that is more prominent in women with ADHD is emotional dysregulation. While emotional difficulties are recognised in ADHD generally, they appear to be particularly pronounced in women. Women with ADHD often describe intense emotional responses, rapid mood shifts, and a low tolerance for frustration. These symptoms are frequently misattributed to mood disorders or personality issues, further delaying diagnosis.

Rejection sensitivity is also common. Individuals with ADHD are more likely to experience peer and social rejection, and this can lead to a heightened sensitivity to perceived rejection or criticism. This is sometimes referred to as rejection sensitive dysphoria (RSD), a term that has gained traction in the ADHD community. While not an official diagnosis, it captures a real and painful aspect of the ADHD experience, particularly for women who have spent years masking their symptoms and fearing exposure.

These emotional aspects of ADHD are often overlooked in diagnostic assessments, which tend to focus on cognitive and behavioural symptoms. Yet for many women, emotional dysregulation is the most impairing aspect of their condition, and it is often what finally drives them to seek help.

Gender Bias in Diagnostic Criteria

Underlying all of these factors is a fundamental gender bias in how ADHD is conceptualised and diagnosed. The diagnostic criteria in the DSM-5 were developed based largely on studies of hyperactive boys. They are more sensitive to the externalising symptoms that are common in males than to the internalising symptoms that are common in females.

This bias is not intentional, but it is pervasive. Clinicians are trained to recognise ADHD based on a male symptom profile, and they may not be aware of how the condition presents differently in women. As one commentary notes, "caregivers, teachers, and health personnel have insufficient knowledge of gender differences in symptom presentation".

The result is a diagnostic system that systematically misses women. When a woman does not fit the stereotypical profile, her symptoms are more likely to be attributed to other causes—anxiety, depression, stress, or personality. This is not just a matter of individual clinician bias; it is embedded in the diagnostic tools and training that clinicians receive.

The Impact of Late Diagnosis

The consequences of delayed diagnosis are not trivial. Women who are diagnosed later in life have often spent years struggling with symptoms they did not understand, attributing their difficulties to personal failings. This can lead to chronic low self-esteem, relationship difficulties, and occupational underachievement.

Research has shown that women with delayed diagnosis have higher rates of co-occurring mental health issues, including depression, anxiety, and somatization disorders. They also have lower life satisfaction and an increased risk of suicidal ideation and self-harm. A systematic review of ADHD in adult women identified four key themes in the experiences of women with undiagnosed ADHD: impacts on social-emotional wellbeing, difficult relationships, lack of control, and self-acceptance after diagnosis.

Late diagnosis also means late treatment. Women can lose an average of five years of treatment, five years of a better life. During those years, they may have been treated for the wrong conditions, received ineffective therapies, or simply endured their symptoms without any support. The delay is not just a statistical artifact; it is a lived reality with profound consequences.

What Can Be Done?

Improving the diagnosis of ADHD in women requires a multi-pronged approach. First, clinicians need better training on the female presentation of ADHD, including the inattentive subtype, masking, and emotional dysregulation. They also need to be aware of the role of hormonal fluctuations and to ask about menstrual cycle phase, pregnancy history, and menopausal status when evaluating symptoms.

Second, diagnostic tools need to be updated to include female-specific norms. As one study notes, "female-specific norms may need to be developed for the different phases of the menstrual cycle to prevent ... underdiagnosis of ADHD in the follicular phase of the cycle". This would help ensure that women are not missed simply because they are assessed at a time when their symptoms are less severe.

Third, there is a need for greater public awareness. Many women do not seek help because they do not recognise their difficulties as symptoms of ADHD. They may believe that ADHD is a condition that only affects hyperactive boys, and that their own struggles are simply personal failings. Education campaigns that highlight the female presentation of ADHD could help women recognise their symptoms and seek appropriate care.

Finally, research on ADHD in women needs to be prioritised. The existing literature is limited, and many of the studies that do exist are based on small samples or are focused on male participants. More research is needed on the female-specific aspects of ADHD, including the impact of hormones, the mechanisms of masking, and the most effective treatment approaches for women.

Table: Symptom Presentation in Women vs. Men with ADHD

Aspect Women Men
Predominant subtype Inattentive (daydreaming, disorganisation) Hyperactive-impulsive (restlessness, impulsivity)
Masking High; develop compensatory strategies, perfectionism Lower; symptoms more visible
Common misdiagnoses Anxiety, depression, borderline personality Conduct disorder, oppositional defiant disorder
Hormonal impact Significant (oestrogen fluctuations affect symptoms) Minimal
Emotional dysregulation More prominent; internalised, mood swings May be externalised as anger or outbursts
Age of diagnosis ~29 years (average) ~24 years (average)
Diagnosis rate 4.2% 13%

Conclusion

ADHD in women is not rare; it is underdiagnosed. The reasons for this are multiple and interconnected: a quieter symptom profile, the pervasive practice of masking, misattribution to anxiety and depression, the influence of hormonal fluctuations, and a diagnostic system that was built around male symptoms. The result is that millions of women spend years—often decades—struggling with unrecognised ADHD, attributing their difficulties to personal failings, and receiving ineffective treatment for the wrong conditions.

Change is possible, but it requires a concerted effort from clinicians, researchers, and the public. By recognising the female presentation of ADHD, updating diagnostic tools, and improving training, we can ensure that women with ADHD are diagnosed earlier and receive the support they need. The cost of inaction is too high—years of lost opportunities, diminished wellbeing, and unnecessary suffering. It is time to close the diagnostic gap.

References

Related Reading on Go-Health

This article is for informational purposes only and does not constitute medical advice. ADHD is a complex neurodevelopmental condition that requires professional assessment and diagnosis. If you or someone you know is experiencing symptoms of ADHD, please consult a qualified healthcare provider. Never start, stop, or change medication without medical supervision.